Publication | Closed Access

Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent

Surgical OncologyMalignant Peritoneal Mesothelioma—resultsMedicinePlatinum AgentPathologyOncologyRadiation OncologyCancer Research